Diabetes News and Research

Latest Diabetes News and Research

Bariatric surgery can reduce pregnancy complications in obese women

Obese women who have bariatric surgery before getting pregnant are at significantly lower risk for developing dangerous hypertensive disorders during pregnancy than those who don't, according to a study of medical insurance records by Johns Hopkins experts.

15 Apr 2010

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a definitive Clinical Trial Agreement (CTA) with the National Institute on Drug Abuse (NIDA) to jointly conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. As part of the CTA, NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the estimated $10 million trial cost.

15 Apr 2010

Interim data from Avid's florbetapir "Image-to-Autopsy" Phase III study to be presented

Avid Radiopharmaceuticals, Inc. today announced the presentation of interim data from its landmark florbetapir "Image-to-Autopsy" Phase III study. These data come from the first cohort of subjects in the trial and are the first ever Phase III results for an agent designed to image Alzheimer's disease pathology.

15 Apr 2010

Phase II GAMMAGARD clinical study for Alzheimer's disease: 18-month results announced

Baxter International Inc. and New York-Presbyterian Hospital/Weill Cornell Medical Center today announced results of an 18-month Phase II clinical study of GAMMAGARD LIQUID and GAMMAGARD S/D [Immune Globulin Intravenous (Human)] (marketed as KIOVIG outside of the U.S.) for mild-to-moderate Alzheimer's disease. This marked the first announcement of clinical trial results measuring function and cognition in patients who received uninterrupted GAMMAGARD for a period of 18 months.

From Baxter International Inc. 15 Apr 2010

Excessive cleanliness can cause allergies

Allergies have become a widespread in developed countries: hay fever, eczema, hives and asthma are all increasingly prevalent. The reason? Excessive cleanliness is to blame according to Dr. Guy Delespesse, a professor at the Universit- de Montr-al Faculty of Medicine.

15 Apr 2010

UnitedHealth partners with Walgreens and YMCA to control diabetes

The New York Times: "The UnitedHealth Group, one of the nation's largest health insurers, is teaming up with the Y.M.C.A. and retail pharmacies to try a new approach to one of the nation's most serious and expensive medical problems: Type 2 Diabetes. Rather than simply continuing to pay ever-higher medical claims to care for its diabetic customers, UnitedHealth is paying the Y.M.C.A. and pharmacists to keep people healthier."

15 Apr 2010

Family support critical for managing patients with chronic health problems

Almost 40 percent of chronically ill older adults in the U.S. live alone, and a majority of those who are married have spouses with at least one chronic illness that can affect their ability to provide support, according to a U-M study published in the journal Chronic Illness.

15 Apr 2010

Tel Aviv University is bioengineering tissues as an alternative to animal testing

It's illegal for health products with medical formulations to be accepted by the U.S. Food and Drug Administration without tests on animals ― a situation that has serious ethical and moral implications. New research in the field of tissue engineering by Prof. Amit Gefen of Tel Aviv University's Faculty of Engineering holds a promise that far fewer lab animals will be needed for the necessary experimental trials.

15 Apr 2010

Use of silver dressing in burn cases questioned

The use of expensive silver dressing in burn cases is being brought under the scanner by an editorial in the Drug and Therapeutics Bulletin. The NHS has increased its spending from £23 million in 2005 to around £25 million in 2006/7 on such products. The author asks if expensive silver dressing is really justified when cheaper alternatives are available.

15 Apr 2010

Financial concerns can delay heart attack treatment

A study published Tuesday in the Journal of the American Medical Association reports that financial concerns can lead people having heart attacks to delay treatment.

15 Apr 2010

Drug company payments to doctors: Continuing controversy

The New York Times has two stories on pharmaceutical industry payments to physicians and experts.

15 Apr 2010

Men who live further from cities more likely to have chronic health problems and higher death rates, says report

According to a new report from the Australian Institute of Health and Welfare, rural men are more prone to succumb to diseases like diabetes, some cancers like of head, neck and lip, poisonings and chronic health problems compared to those living in major cities.

14 Apr 2010

Alkermes submits VIVITROL sNDA for opioid dependence

Alkermes, Inc. today announced that it has submitted a supplemental New Drug Application (sNDA) for VIVITROL® (naltrexone for extended-release injectable suspension) to the U.S. Food and Drug Administration (FDA) for approval as a treatment for opioid dependence. The company requested a priority review for its sNDA and if granted by the FDA, it would mean a six month review timeline.

13 Apr 2010

IVAX Diagnostics signs two-year distribution agreement with Biomerica

IVAX Diagnostics, Inc., a fully integrated in vitro diagnostics company, and Biomerica, Inc., a global biomedical company, have signed a two-year agreement for the distribution of Biomerica's products in the U.S. and globally, with certain country and product exclusions.

13 Apr 2010

Woodford Reserve $1,000 Mint Julep Cup: The Barnstable Brown Kentucky Diabetes & Obesity Center beneficiary

Woodford Reserve bourbon will celebrate the glamour and glitz of the Kentucky Derby® with the Ultimate Kentucky Derby Luxury: the world's most exclusive mint julep cup. The Woodford Reserve $1,000 Mint Julep Cup Experience will feature a collection of 73 silver cups designed by Tiffany & Co. exclusively for Woodford Reserve. Proceeds from the cups will benefit The Barnstable Brown Kentucky Diabetes & Obesity Center.

13 Apr 2010

Researchers discover two synthetic small molecule drugs to prevent death of human stem cell

Scientists at The Scripps Research Institute have solved the decade-old mystery of why human embryonic stem cells are so difficult to culture in the laboratory, providing scientists with useful new techniques and moving the field closer to the day when stem cells can be used for therapeutic purposes.

13 Apr 2010

Health care professionals urge Congress to support nation's chemical regulatory reform

On the eve of legislation slated to be introduced this month to reform the Toxic Substances Control Act, almost two dozen organizations representing health care professionals, along with health sector businesses sent letters to Congress urging the passage of strong reform of our nation's chemical regulatory system.

13 Apr 2010

$15M grant to support research and development of new health care IT infrastructure

Researchers at Children's Hospital Boston and Harvard Medical School will lead the efforts of a $15 million grant recently announced from the Office of the National Coordinator for Health Information Technology in the Department of Health and Human Services to support research and development of a new health care information technology infrastructure.

13 Apr 2010

XOMA expands anti-inflammatory antibody intellectual property portfolio

XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that the U.S. Patent and Trademark Office has issued two new patents that significantly expand the company's intellectual property portfolio relating to its anti-inflammatory antibody, XOMA 052, that targets interleukin-1 beta (IL-1 beta).

13 Apr 2010

Yearly flu shots recommended for adults in 50-64 age group

The proportion of Americans with diabetes ages 18 to 64 who reported getting flu shots the previous year rose from 40 percent to 50.5 percent between 2000 and 2007, according to the latest News and Numbers from the Agency for Healthcare Research and Quality.

13 Apr 2010

Diabetes News and Research

Latest Diabetes News and Research

Bariatric surgery can reduce pregnancy complications in obese women

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

Interim data from Avid's florbetapir "Image-to-Autopsy" Phase III study to be presented

Phase II GAMMAGARD clinical study for Alzheimer's disease: 18-month results announced

Excessive cleanliness can cause allergies

UnitedHealth partners with Walgreens and YMCA to control diabetes

Family support critical for managing patients with chronic health problems

Tel Aviv University is bioengineering tissues as an alternative to animal testing

Use of silver dressing in burn cases questioned

Financial concerns can delay heart attack treatment

Drug company payments to doctors: Continuing controversy

Men who live further from cities more likely to have chronic health problems and higher death rates, says report

Alkermes submits VIVITROL sNDA for opioid dependence

IVAX Diagnostics signs two-year distribution agreement with Biomerica

Woodford Reserve $1,000 Mint Julep Cup: The Barnstable Brown Kentucky Diabetes & Obesity Center beneficiary

Researchers discover two synthetic small molecule drugs to prevent death of human stem cell

Health care professionals urge Congress to support nation's chemical regulatory reform

$15M grant to support research and development of new health care IT infrastructure

XOMA expands anti-inflammatory antibody intellectual property portfolio

Yearly flu shots recommended for adults in 50-64 age group

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Diabetes News and Research

Latest Diabetes News and Research

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Evolving spectrophotometry for modern biopharma workflows

Newsletters you may be interested in